MMedication Read More This herb can improve brain function, slash stress, and even reduce inflammationAugust 7, 2025 Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The…
MMedication Read More New Hand Eczema Treatment Anzupgo (Delgocitinib) Gets FDA OkayAugust 7, 2025 With the U.S. Food and Drug Administration (FDA) approval of Anzupgo (delgocitinib), adults dealing with persistent hand eczema…
MMedication Read More FDA approves Vizz eye drops to improve near vision in adultsAugust 7, 2025 The U.S. Food and Drug Administration has approved Vizz 1.44% (aceclidine ophthalmic solution) for the treatment of presbyopia…
MMedication Read More Advertising unapproved medicines not legal, despite government claimAugust 6, 2025 In a statement, Minister for Regulation David Seymour said the restriction on advertising new medicines at medical conferences…
MMedication Read More Gov. Hobbs signs executive order to lower cost of prescription drugs in ArizonaAugust 6, 2025 PHOENIX (AZFamily) — A new executive order signed by Gov. Katie Hobbs aims to lower the cost of…
MMedication Read More FDA Marks 7-OH, Kratom Compound With Opioid Effect, for CSA Schedule IAugust 6, 2025 The Food and Drug Administration is recommending that 7-hydroxymitragynine, commonly referred to as 7-OH, be federally scheduled under…
MMedication Read More Lilly Downplaying Obesity Drug Side Effects, Indiana Lawsuits Claim – InkFreeNews.comAugust 6, 2025 At least 26 patients have filed lawsuits in Marion County against Eli Lilly and Co. Photo from Wikimedia…
MMedication Read More A ‘public medicine chest’ grows by I-280August 6, 2025 Read Mission Local often? Help grow our newsroom, joining the hundreds of San Franciscans who support us by…
MMedication Read More Giant Eagle to join Mark Cuban’s prescription drug discount programAugust 6, 2025 Giant Eagle is joining the Mark Cuban-backed Cost Plus Drugs network, an effort aimed at reducing drug prices…
MMedication Read More FDA Approves Expanded Indication for AJOVY® (fremanezumab-vfrm), The First Anti-CGRP Preventive Treatment for Pediatric Episodic MigraineAugust 6, 2025 Teva Pharmaceutical Industries Ltd FDA approves single-dose AJOVY® (fremanezumab-vfrm) injection for the preventive treatment of episodic migraine in…